Antioxidant |
SOD, MDA, TEAC |
Stem-branch/Curde polysaccharide |
Lentinan (630 mg/kg) showed similar in vivo antioxidant activity to the extract |
in vivo: 50, 100, 200 mg/kg |
Increasing SOD TEAC leveals, decreasing MDA levels |
Liu et al. (2021)
|
Hepatoprotective effects |
APAP-induced acute liver injury mice |
Secretory/Aqueous |
Silibinin (300 mg/kg) significantly inhibits ALT, AST activity and alleviates liver lesions caused by APAP |
in vivo: 150, 300, 600 mg/kg |
Inhibiting the release of ALT and AST caused by APAP overdose and alleviating APAP-induced liver injury and hepatocyte necrosis |
Aili et al. (2017)
|
Alcoholic-induced acute liver injury mice |
Secretory/Aqueous |
Silibinin has a protective effect in mice with alcoholic liver disease |
in vivo: 150, 300, 600 mg/kg |
promoting alcohol metabolism, reducing the expression levels of TNF-α and TLR4 mRNA, promoting liver tissue repair and hepatocyte regeneration |
Kuerbanjiang et al. (2017)
|
Renoprotective effects |
Gentamicin-induced subacute renal injury mice |
Secretory/Aqueous |
— |
in vivo: 350 mg/kg |
significant protective effect on renal injury caused by 125 and 80 mg/kg GM, but not on renal injury caused by 100 mg/kg GM |
Mikeremu et al. (2013)
|
HgCl2- induced subacute renal injury in mice |
Secretory/Aqueous |
— |
in vivo: 150, 300, 750 mg/kg |
Best renal protection at 150 mg/ml |
Wumaierjiang et al. (2014)
|
Gastrointestinal effects |
Atropine inhibition and bethanechol chloride promote small bowel motility |
Secretory/Aqueous |
— |
in vivo: 750, 1,500, 3,000 mg/kg |
Gastrointestinal motility is stimulated and inhibited by excited gastrointestinal motility |
Mikeremu et al. (2017)
|
Diarrheal irritable bowel syndrome rats |
Aerial part/ethanol |
TrimebutineMaleate (60 mg/kg) improves diarrhoeal irritable bowel syndrome |
in vivo: 200, 400 mg/kg |
The fecal moisture content, the AWR score and the level of 5- HT, SP, MTL in the high and low dose groups were significantly decreased, and the number of fecal grains increased significantly |
Liu et al. (2019b)
|
Diarrheal irritable bowel syndrome rats |
Aerial part/ethanol |
TrimebutineMaleate (60 mg/kg) improves diarrhoeal irritable bowel syndrome |
in vivo: 200, 400 mg/kg |
At the concentration of 400 mg/kg, the extract significantly reduced wall electrical activity and increased NO levels |
Ma et al. (2018c)
|
Affecting the survival rate |
dry and hot environment rat |
Aerial part/ethanol |
— |
in vivo: 100, 330, 1,000 mg/kg |
Delaying the rise in core body temperature to improve heat tolerance in dry heat tolerance in rats in a dry heat environment |
Dong et al. (2019)
|
Immune regulation |
RAW264.7 cells in mice |
Secretory/Aqueous |
Lipopolysaccharide (1,000 μg/ml) promote macrophage proliferation but are less active than extract (100, 200 μg/ml) |
in vitro: 12.5, 25, 50, 100, 200 μg/ml |
Promoting macrophage proliferation and having a positive regulatory effect on immune activity |
Han et al. (2017)
|
CY and DNCB induced delayed type hypersensitivity of immunosuppression mice |
Aerial part/BuOH |
— |
in vivo: 100, 200, 400 mg/kg |
Enhancing the swollen degree of auricle, resisting the atrophy of spleen and thymus and increasing the index of immune organs |
Ma et al. (2017)
|
Anti-tumor |
BGC-82, Eca-10, HT-29 and HepG2 cancer cells |
Aerial part/ethanol |
The IC50 values of Cisplatin for BGC-823, Eca-109, HT-29 and HepG2 cells were 0.019, 0.204, 0.0858, 0.0392 |
in vitro: 10, 5, 2.5, 1.25, 0.625, 0.156, 0.039 mg/ml |
The IC50 values of BGC-823, Eca-109, HT-29 and HepG2 cells were 1.62, 1.32, 1.55 and 1.45 mg/ml respectively |
Ma et al. (2015)
|
CT26 colon cancer mice |
Inhibition rate of 98% in CT26 colon cancer mice by cyclophosphamide (50 mg/kg) |
in vivo: 100, 200, 1,000 mg/kg |
The inhibition rate was 24.8% in the high dose group, 0.06% in the medium dose group and -0.05% in the low dose group in vivo
|
Hela, Ht-29, HepG2, BGC823 and KB tumour cells |
Aerial part/EtOAc, BuOH, Compound 11, 65, 66, 98 and 167
|
— |
in vitro: 200, 100, 50, 25, 12.5, 6.25 μg/ml |
inhibiting the proliferation and migration of Hela, Ht-29, HepG2, BGC823 and KB tumour cells in a dose-dependent manner |
Ma et al. (2018b)
|
Anti-neuroinflammatory |
LPS-induced N9 cells |
Aerial part/ethanol |
The IC50 values of minocycline for LPS-induced N9 cells was 19.89 |
in vitro:/
|
Compound 3, 4, 32, 37, 170, 171, 54, and 167 showed much stronger anti-neuroinflammatory effects than minocycline |
Zhou et al. (2017)
|